TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,389 | +303.3% | 3,736 | +310.1% | 0.00% | +100.0% |
| Q2 2023 | $16,461 | +149545.5% | 911 | +4.8% | 0.00% | – |
| Q1 2023 | $11 | 0.0% | 869 | +17.1% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 742 | -50.2% | 0.00% | – |
| Q3 2022 | $26,000 | -31.6% | 1,490 | -43.4% | 0.00% | -100.0% |
| Q2 2022 | $38,000 | -64.8% | 2,631 | -59.0% | 0.00% | 0.0% |
| Q1 2022 | $108,000 | +671.4% | 6,424 | +885.3% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 652 | +40.2% | 0.00% | – |
| Q3 2021 | $10,000 | -70.6% | 465 | -60.4% | 0.00% | -100.0% |
| Q2 2021 | $34,000 | +183.3% | 1,173 | +219.6% | 0.00% | – |
| Q1 2021 | $12,000 | -55.6% | 367 | -43.1% | 0.00% | -100.0% |
| Q4 2020 | $27,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |